| 000 | 01753cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030551.0 | ||
| 008 | 120219s2011 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.08.08.Ph.D.2011.Ha.F | ||
| 100 | 0 | _aHadel Aly Mohammed Aly Aboelenin | |
| 245 | 1 | 0 |
_aFormulation and Evaluation of certain antihypertensive drug in specific dosage form / _cHadel Aly Mohammed Aly Aboelenin ; Supervised Saadeya A. Tayel , Mohamed A. Elnabarawi , Nadia Abdelkader Soliman |
| 246 | 1 | 5 | _aصياغة وتقييم عقار مضاد لأرتفاع ضغط الدم فى مستحضرات صيدلى محدد |
| 260 |
_aCairo : _bHadel Aly Mohammed Aly Aboelenin , _c2011 |
||
| 300 |
_a238 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics | ||
| 520 | _aA stress induced rise in blood pressure . Some belive that patients with hypertension are characterized by a generalized state of increased anxiety . The purpose of the study is to prepare fixed dose bi therapy using bisoprolol hemifumarate as antihypertensive drug and buspirone hydrochloride as anxiolytic drug which can be used to treat both diseases concomitantly | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aBi therapy | |
| 653 | 4 | _aBisoprolol hemifumarate | |
| 653 | 4 | _aBuspiron Hydrochlorid | |
| 700 | 0 |
_aMohamed Ahmed Elnabarawi , _eSupervisor |
|
| 700 | 0 |
_aNadia Abdelkader Soliman , _eSupervisor |
|
| 700 | 0 |
_aSaadeya Ahmed Tayel , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c37440 _d37440 |
||